Arrestin Interaction with E3 Ubiquitin Ligases and Deubiquitinases: Functional and Therapeutic Implications
- 5 November 2013
- book chapter
- Published by Springer Nature
- Vol. 219, 187-203
Abstract
Arrestins constitute a small family of four homologous adaptor proteins (arrestins 1–4), which were originally identified as inhibitors of signal transduction elicited by the seven-transmembrane G protein-coupled receptors. Currently arrestins (especially arrestin2 and arrestin3; also called β-arrestin1 and β-arrestin2) are known to be activators of cell signaling and modulators of endocytic trafficking. Arrestins mediate these effects by binding to not only diverse cell-surface receptors but also by associating with a variety of critical signaling molecules in different intracellular compartments. Thus, the functions of arrestins are multifaceted and demand interactions with a host of proteins and require an array of selective conformations. Furthermore, receptor ligands that specifically induce signaling via arrestins are being discovered and their physiological roles are emerging. Recent evidence suggests that the activity of arrestin is regulated in space and time by virtue of its dynamic association with specific enzymes of the ubiquitination pathway. Ubiquitin-dependent, arrestin-mediated signaling could serve as a potential platform for developing novel therapeutic strategies to target transmembrane signaling and physiological responses.Keywords
This publication has 85 references indexed in Scilit:
- β-arrestin-mediated receptor trafficking and signal transductionTrends in Pharmacological Sciences, 2011
- Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signalingTrends in Biochemical Sciences, 2011
- A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1Nature, 2011
- Ubiquitin Ligase Parkin Promotes Mdm2–Arrestin Interaction but Inhibits Arrestin UbiquitinationBiochemistry, 2011
- Therapeutic potential of β-arrestin- and G protein-biased agonistsTrends in Molecular Medicine, 2011
- Custom-designed proteins as novel therapeutic tools? The case of arrestinsExpert Reviews in Molecular Medicine, 2010
- The deubiquitinases USP33 and USP20 coordinate β2 adrenergic receptor recycling and resensitizationThe EMBO Journal, 2009
- Ubiquitin ligase adaptors: Regulators of ubiquitylation and endocytosis of plasma membrane proteinsExperimental Cell Research, 2009
- Regulation of Smurf2 Ubiquitin Ligase Activity by Anchoring the E2 to the HECT DomainMolecular Cell, 2005
- Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in CellsJournal of Medicinal Chemistry, 2005